• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by Cibus Inc.

    3/24/25 5:22:06 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials
    Get the next $CBUS alert in real time by email
    S-8 1 d927420ds8.htm S-8 S-8

    As filed with the Securities and Exchange Commission on March 24, 2025

    Registration No. 333-   

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

    FORM S-8

    REGISTRATION STATEMENT

    UNDER

    THE SECURITIES ACT OF 1933

     

     

    Cibus, Inc.

    (Exact name of registrant as specified in its charter)

     

     

     

    Delaware   27-1967997

    (State or other jurisdiction of

    incorporation or organization)

     

    (I.R.S. Employer

    Identification No.)

    6455 Nancy Ridge Drive

    San Diego, CA 92121

    (Address of Principal Executive Offices, Including Zip Code)

    CIBUS, INC. 2017 OMNIBUS INCENTIVE PLAN

    (Full title of the plan)

    Peter Beetham

    Interim Chief Executive Officer

    6455 Nancy Ridge Drive

    San Diego, CA 92121

    (Name and address of agent for service)

    (858) 450-0008

    (Telephone number, including area code, of agent for service)

    Copies to:

    Peter E. Devlin

    Erik B. Lundgren

    Jones Day

    250 Vesey Street

    New York, NY 10281

    (212) 326-3939

     

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

    Large accelerated filer   ☐    Accelerated filer   ☐
    Non-accelerated filer   ☒    Smaller reporting company   ☒
         Emerging growth company   ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

     

     

     


    REGISTRATION OF ADDITIONAL SECURITIES

    PURSUANT TO GENERAL INSTRUCTION E

    Pursuant to General Instruction E to Form S-8, this Registration Statement is being filed for the purpose of registering an additional 4,000,000 shares of Class A common stock, par value $0.0001 per share, of Cibus, Inc. (the “Company” or the “Registrant”) authorized for issuance pursuant to the Cibus, Inc. 2017 Omnibus Incentive Plan, as amended, which is the same class as the securities previously registered for issuance thereunder on effective Registration Statements on Form S-8 filed with the Securities and Exchange Commission on July 20, 2017 (File No. 333-219382), May 9, 2019 (File No. 333-231336), July 16, 2021 (File No. 333-257972), March 2, 2023 (File No. 333-270245), May 24, 2023 (File No. 333-272177) and June 30, 2023 (File No. 333-273069) (collectively, the “Prior Registration Statements”). The contents of the Prior Registration Statements are incorporated by reference into this Registration Statement.

    PART II

    INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

    Item 3. Incorporation of Documents by Reference

    The following documents filed by the Registrant with the Securities and Exchange Commission (the “Commission”) are incorporated by reference into this Registration Statement:

     

      •  

    the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 (including the information in Part III incorporated therein by reference from the Company’s Definitive Proxy Statement on Schedule 14A for the year ended December 31, 2024);

     

      •  

    the Company’s Current Reports on Form 8-K filed on January 22, 2025 and February 28, 2025 (in each case, excluding any information furnished and not filed with the Commission); and

     

      •  

    the description of the Company’s Class  A Common Stock contained in our Registration Statement on Form 8-A, filed on July 20, 2017, as the description therein has been updated and superseded by the description of securities contained in Exhibit 99.1 to our Current Report on Form 8-K filed with the SEC on June 29, 2023, including any amendments or reports filed for the purpose of updating the description.

    In addition, all other reports and documents subsequently filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934, prior to the filing of a post-effective amendment to this Registration Statement which indicates that all securities offered have been sold or which deregisters all securities remaining unsold, shall be deemed to be incorporated by reference in this Registration Statement and to be part hereof from the date of filing of such reports or documents.

    Any statement contained herein, or in a document incorporated or deemed to be incorporated by reference herein, shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained in any subsequently filed document that also is deemed to be incorporated by reference herein, modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.


    Item 8. Exhibits.

     

    Exhibit
    No.
      

    Description of Exhibit

      4.1    Second Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.2 of the Company’s Current Report on Form 8-K filed with the Commission on June 1, 2023).
      4.2    Amended and Restated Bylaws (incorporated by reference to Exhibit 3.3 of the Company’s Current Report on Form 8-K filed with the Commission on June 1, 2023).
      5.1*    Opinion of Jones Day.
     23.1*    Consent of BDO USA, P.C.
     23.2*    Consent of Jones Day (included in Exhibit 5.1).
     24.1*    Power of Attorney (included in the signature page to this Registration Statement).
     99.1    Cibus, Inc. 2017 Omnibus Incentive Plan, as amended (incorporated by reference to Exhibit 10.7 of the Company’s Current Report on Form 8-K filed with the SEC on June 1, 2023).
     99.2    Cibus, Inc. (f/k/a Calyxt, Inc.) 2017 Stock Option Sub-Plan for French Employees and Directors (incorporated by reference to Exhibit 10.21 to the Company’s Registration Statement on Form S-1 filed on July 3, 2017 (File No. 333—218924)).
     99.3    Form of Stock Option Agreement pursuant to the Cibus, Inc. (f/k/a Calyxt, Inc.) 2017 Omnibus Incentive Plan, as amended (incorporated by reference to Exhibit 10.3 the Company’s Form 10-Q for the quarter ended June 30, 2020).
     99.4    Form of Restrictive Stock Unit (Employees) pursuant to the Cibus, Inc. (f/k/a Calyxt, Inc.) 2017 Omnibus Incentive Plan, as amended (incorporated by reference to Exhibit 10.18 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2024).
     99.5    Form of Stock Option Agreement (Employees) pursuant to the Cibus, Inc. (f/k/a Calyxt, Inc.) 2017 Omnibus Incentive Plan, as amended (incorporated by reference to Exhibit 10.19 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2024).
     99.6    Form of Restricted Stock Unit Agreement (Directors) pursuant to the Cibus, Inc. (f/k/a Calyxt, Inc.) 2017 Omnibus Incentive Plan, as amended (incorporated by reference to Exhibit 10.20 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2024).
     99.7    Form of Stock Option Agreement (Directors) pursuant to the Cibus, Inc. (f/k/a Calyxt, Inc.) 2017 Omnibus Incentive Plan, as amended (incorporated by reference to Exhibit 10.21 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2024).
     99.8*    Form of Restricted Stock Agreement (incorporated by reference to Exhibit 99.10 to the Company’s Registration Statement on Form S-8 filed with the SEC on June 30, 2023).
    107*    Filing Fee Table

     

    *

    Filed herewith.


    SIGNATURES

    Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of San Diego, State of California, on March 24, 2025.

     

    Cibus, Inc.

     

    By:   /s/ Peter Beetham
    Name:   Peter Beetham
    Title:   Interim Chief Executive Officer

    POWER OF ATTORNEY

    The undersigned directors and officers of Cibus, Inc. hereby appoint each of Peter Beetham and Cornelis (Carlo) Broos as attorneys-in-fact for the undersigned, with full power of substitution for, and in the name, place and stead of the undersigned, to sign and file with the Securities and Exchange Commission under the Securities Act of 1933, any and all amendments (including post-effective amendments) and exhibits to this Registration Statement on Form S-8 and any and all applications and other documents to be filed with the Securities and Exchange Commission pertaining to the registration of the securities covered hereby, with full power and authority to do and perform any and all acts and things whatsoever requisite and necessary or desirable, hereby ratifying and confirming all that said attorney-in-fact, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

    Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated below.

     

    Signature

      

    Title

     

    Date

    /s/ Peter Beetham

    Peter Beetham

      

    Interim Chief Executive Officer and Director

    (Principal Executive Officer)

      March 24, 2025

    /s/ Cornelis (Carlo) Broos

    Cornelis (Carlo) Broos

      

    Interim Chief Financial Officer

    (Principal Financial and Accounting Officer)

      March 24, 2025

    /s/ Rory Riggs

    Rory Riggs

       Chairman of the Board of Directors   March 24, 2025

    /s/ Mark Finn

    Mark Finn

       Director   March 24, 2025

    /s/ Jean-Pierre Lehmann

    Jean-Pierre Lehmann

       Director   March 24, 2025

    /s/ Gerhard Prante

    Gerhard Prante

       Director   March 24, 2025

    /s/ Keith Walker

    Keith Walker

       Director   March 24, 2025

    /s/ August Moretti

    August Moretti

       Director   March 24, 2025
    Get the next $CBUS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CBUS

    DatePrice TargetRatingAnalyst
    7/29/2024$25.00Buy
    Alliance Global Partners
    7/19/2024$22.00Buy
    Canaccord Genuity
    10/9/2023$25.00Buy
    H.C. Wainwright
    7/19/2023$30.00Buy
    Canaccord Genuity
    More analyst ratings

    $CBUS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cibus Partnering with The John Innes Centre for UK Government's Farming Innovation Programme Precision Breeding Initiative

    Cibus to utilize proprietary Rapid Trait Development System™ to enable development of durable resistance to Light Leaf Spot disease, which has caused estimated yield losses of up to £300m in recent years SAN DIEGO, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) (the "Company" or "Cibus"), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced its participation as a key technology partner in a landmark research and development project funded by the UK Government's Department for Environment, Food & Rural Affairs (Defra), underscoring the potential benefits of gene editing for enabling crop improvement and innovati

    2/6/26 7:00:00 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    Cibus, Inc. Announces Pricing of $20.0 Million Public Offering of Class A Common Stock

    SAN DIEGO, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) (the "Company" or "Cibus"), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced the pricing of an underwritten public offering of 13,333,333 shares of its Class A Common Stock, par value $0.0001 per share ("Class A Common Stock"), at a public offering price of $1.50 per share (the "Offering"). Members of Cibus' Board of Directors will purchase 1,000,000 shares of Class A Common Stock in the Offering at the public offering price. The Company has also granted the underwriter a 30-day option to purchase up to an additional 1,999,999 shares of Class A Common

    1/29/26 7:00:00 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    Cibus, Inc. Announces Proposed Public Offering of Class A Common Stock

    SAN DIEGO, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) (the "Company" or "Cibus"), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that it intends to offer shares of its Class A common stock, par value $0.0001 per share ("Class A Common Stock"), in an underwritten public offering (the "Offering"). Cibus also expects to grant to the underwriter of the Offering a 30-day option to purchase up to an additional 15% of the shares of Class A Common Stock offered in the Offering on the same terms and conditions. The Offering is subject to market and other conditions, and there can be no assurance as to whether or

    1/28/26 4:05:00 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    $CBUS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Lehmann Jean-Pierre Jules was granted 666,666 shares, increasing direct ownership by 2,052% to 699,156 units (SEC Form 4)

    4 - Cibus, Inc. (0001705843) (Issuer)

    2/2/26 8:31:25 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    Director Riggs Rory B was granted 333,333 shares, increasing direct ownership by 2% to 14,916,640 units (SEC Form 4)

    4 - Cibus, Inc. (0001705843) (Issuer)

    2/2/26 8:27:33 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    SEC Form 4 filed by Director Wichner Craig

    4 - Cibus, Inc. (0001705843) (Issuer)

    11/25/25 1:54:02 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    $CBUS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Alliance Global Partners initiated coverage on Cibus Global with a new price target

    Alliance Global Partners initiated coverage of Cibus Global with a rating of Buy and set a new price target of $25.00

    7/29/24 7:49:52 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    Canaccord Genuity resumed coverage on Cibus Global with a new price target

    Canaccord Genuity resumed coverage of Cibus Global with a rating of Buy and set a new price target of $22.00

    7/19/24 8:34:00 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    H.C. Wainwright initiated coverage on Cibus Global with a new price target

    H.C. Wainwright initiated coverage of Cibus Global with a rating of Buy and set a new price target of $25.00

    10/9/23 8:32:05 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    $CBUS
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Cibus Inc.

    SCHEDULE 13G/A - Cibus, Inc. (0001705843) (Subject)

    2/5/26 1:20:38 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    SEC Form 8-K filed by Cibus Inc.

    8-K - Cibus, Inc. (0001705843) (Filer)

    1/30/26 8:45:46 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    SEC Form 424B5 filed by Cibus Inc.

    424B5 - Cibus, Inc. (0001705843) (Filer)

    1/29/26 6:54:57 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    $CBUS
    Financials

    Live finance-specific insights

    View All

    Cibus Reports Third Quarter Financial Results and Provides Year-to-Date Business Update for 2025

    With the addition of Centro Internacional de Agricultura Tropical (CIAT) in the quarter, Cibus now has 5 LATAM Rice customers as momentum continues toward achieving 2027 targeted initial LATAM Rice revenue On track to deliver HT traits to Latin American customer in Q4 2025 with field trials expected to commence by year end Engaged strategic growth advisory firm AgVayā to introduce Indian Rice growers to new solutions to scale crop productivity through advanced gene editing Successfully completed pre-commercial pilot runs for certain biofragrance products; commercial expansion targeted for 2026 Positive field trial results for HT2 in Canola in North America; HT2 and Sclerotinia resistance

    11/13/25 4:05:00 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    Cibus to Report Third Quarter 2025 Financial Results on November 13, 2025 After the Market Close and Host Conference Call

    SAN DIEGO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that the company will report third quarter 2025 financial results on Thursday, November 13, 2025. Cibus' management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates. Title: Cibus, Inc. Third Quarter 2025 Results Conference Call Event Date: Thursday, November 13, 2025         Time: 4:30 p.m. ET         Participant Numbers: +1-800-274-8461 (U.S.), +1-203-518-9814 (International)The conference ID "CIBUS" or 24287 will

    10/30/25 4:05:00 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    Cibus to Report Second Quarter 2025 Financial Results on August 14, 2025 After the Market Close and Host Conference Call

    SAN DIEGO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that the company will report second quarter 2025 financial results on Thursday, August 14, 2025. Cibus' management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates. Title: Cibus, Inc. Second Quarter 2025 Results Conference Call Event Date: Thursday, August 14, 2025Time: 4:30 p.m. ETParticipant Numbers: +1-833-316-2483 (U.S.), +1-785-838-9284 (International)The conference ID "CIBUS" or 24287 will be required for en

    8/5/25 7:00:00 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    $CBUS
    Leadership Updates

    Live Leadership Updates

    View All

    Cibus Announces the Election of Craig Wichner to Board of Directors

    SAN DIEGO, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced the election of Craig Wichner to its Board of Directors. Mr. Wichner will also serve as a member of the Board's current Strategy Committee. "Craig brings an exceptional combination of financial acumen, strategic discipline, and industry insight to the Cibus Board," said Mark Finn, Chairman of the Board of Cibus. "As Cibus prepares for anticipated commercial scaling of our trait platform, Craig's expertise in sustainable growth and capital strategy in agriculture will be instrumental in strengthening our

    11/11/25 7:00:00 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    Cibus Announces the Election of Kimberly A. Box to Board of Directors

    SAN DIEGO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ: CBUS), a leading agricultural technology company developing and licensing advanced plant traits that enable higher yields, lower input costs, and more sustainable farming, today announced the election of Kimberly A. Box to its Board of Directors. "Kim brings to Cibus extensive leadership experience in technology and commercialization that will be invaluable as we sharpen our strategic commercialization efforts," said Mark Finn, Cibus Chairman. "Her understanding of market dynamics and experience in guiding innovation into scalable businesses will strengthen our strategic governance as we continue to drive long-term value c

    9/25/25 4:05:00 PM ET
    $CBUS
    $MGRC
    Agricultural Chemicals
    Industrials
    Diversified Commercial Services
    Consumer Discretionary

    Cibus CEO to Highlight Gene Editing's Role in Building Resilient Agriculture at UN Climate Week 2025

    SAN DIEGO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company specializing in the development and licensing of gene-edited plant traits, today announced that Peter Beetham, Co-Founder, President, and Interim Chief Executive Officer, will participate in a featured panel during UN Climate Week 2025 in New York City. The event, titled "Investing in a Resilient Future: Innovation, Data & Capital for Energy, Food, Water, and Climate Solutions", supported by Syntax Data, will be held on Tuesday, September 23rd at Midtown Loft, New York City, with a livestream available via LinkedIn. Dr. Beetham will join leaders from the United Nations Devel

    9/22/25 12:10:00 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials